STAAR Surgical Company appointed Warren Foust as President and Chief Executive Officer, effective August 4, 2026, adding him to the Board of Directors. Mr. Foust receives a $730,000 annual base salary and significant equity grants including RSUs and performance-based stock options with hurdles at $50, $75, and $100 per share. Deborah Andrews transitions from Interim Co-CEO to Executive Vice President while retaining her role as Chief Financial Officer. This leadership change follows an extensive global search aimed at driving revenue growth and innovation in the ophthalmic surgery industry.
